Follow
ANTONIO PAGLIUCA
ANTONIO PAGLIUCA
Professor of Haematology
Verified email at kcl.ac.uk
Title
Cited by
Cited by
Year
The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS
JE Parker, GJ Mufti, F Rasool, A Mijovic, S Devereux, A Pagliuca
Blood, The Journal of the American Society of Hematology 96 (12), 3932-3938, 2000
4532000
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 51 (7), 906-912, 2016
3382016
Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome
RK Patel, NC Lea, MA Heneghan, NB Westwood, D Milojkovic, ...
Gastroenterology 130 (7), 2031-2038, 2006
3202006
BCSH/BSBMT guideline: diagnosis and management of veno‐occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation
FL Dignan, RF Wynn, N Hadzic, J Karani, A Quaglia, A Pagliuca, P Veys, ...
British journal of haematology 163 (4), 444-457, 2013
2862013
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation
DI Marks, A Pagliuca, CC Kibbler, A Glasmacher, CP Heussel, M Kantecki, ...
British journal of haematology 155 (3), 318-327, 2011
2622011
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine …
AYL Ho, A Pagliuca, M Kenyon, JE Parker, A Mijovic, S Devereux, ...
Blood 104 (6), 1616-1623, 2004
2402004
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and …
S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ...
Bone marrow transplantation 53 (2), 138-145, 2018
2132018
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
RD Faulkner, C Craddock, JL Byrne, P Mahendra, AP Haynes, ...
Blood 103 (2), 428-434, 2004
2042004
Nonmyeloablative stem cell transplantation for congenital immunodeficiencies
P Amrolia, HB Gaspar, A Hassan, D Webb, A Jones, N Sturt, ...
Blood, The Journal of the American Society of Hematology 96 (4), 1239-1246, 2000
1872000
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia
JC Marsh, V Gupta, ZY Lim, AY Ho, RM Ireland, J Hayden, V Potter, ...
Blood, The Journal of the American Society of Hematology 118 (8), 2351-2357, 2011
1742011
'Low-risk'myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic bcl-2-related proteins.
JE Parker, KL Fishlock, A Mijovic, B Czepulkowski, A Pagliuca, GJ Mufti
British journal of haematology 103 (4), 1075-1082, 1998
1651998
Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab
AGS Buggins, GJ Mufti, J Salisbury, J Codd, N Westwood, M Arno, ...
Blood, The Journal of the American Society of Hematology 100 (5), 1715-1720, 2002
1622002
Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia
JE Parker, A Pagliuca, A Mijovic, JO Cullis, B Czepulkowski, ...
British journal of haematology 99 (4), 939-944, 1997
1621997
Retrospective comparison of bone marrow and granulocyte colony-stimulating factor–mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA …
P Guardiola, V Runde, A Bacigalupo, T Ruutu, F Locatelli, MA Boogaerts, ...
Blood, The Journal of the American Society of Hematology 99 (12), 4370-4378, 2002
1592002
Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis with prior exposure to Janus kinase 1/2 inhibitors
M Shanavas, U Popat, LC Michaelis, V Fauble, D McLornan, R Klisovic, ...
Biology of Blood and Marrow Transplantation 22 (3), 432-440, 2016
1492016
Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning
K Raj, A Pagliuca, K Bradstock, V Noriega, V Potter, M Streetly, ...
Biology of Blood and Marrow Transplantation 20 (6), 890-895, 2014
1442014
Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002
AR Gennery, K Khawaja, P Veys, RGM Bredius, LD Notarangelo, ...
Blood 103 (3), 1152-1157, 2004
1442004
Liver transplantation for Budd-Chiari syndrome
P Srinivasan, M Rela, A Prachalias, P Muiesan, B Portmann, GJ Mufti, ...
Transplantation 73 (6), 973-977, 2002
1392002
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ...
The Lancet 396 (10266), 1885-1894, 2020
1362020
Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia
J Clay, AG Kulasekararaj, V Potter, F Grimaldi, D McLornan, K Raj, ...
Biology of Blood and Marrow Transplantation 20 (11), 1711-1716, 2014
1242014
The system can't perform the operation now. Try again later.
Articles 1–20